• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Tris Pharma® Acquires Park Therapeutics americanpharmaceuticalreview
    April 30, 2021
    Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, has acquired Park ...
  • Tris Pharma, Athena Bioscience Enter Exclusive License Agreement contractpharma
    February 23, 2021
    Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service